Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Market Cap	25.34B
Revenue (ttm)	14.35B
Net Income (ttm)	2.16B
Shares Out	4.55B
EPS (ttm)	0.47
PE Ratio	11.82
Forward PE	10.41
Dividend	0.23 (4.22%)
Ex-Dividend Date	Oct 20, 2025

Volume	10,596,036
Average Volume	18,447,624
Open	5.60
Previous Close	5.63
Day's Range	5.52 - 5.68
52-Week Range	4.09 - 7.39
Beta	0.36
RSI	35.52
Earnings Date	Nov 11, 2025

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1988
• Employees: 12,719
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2024, HKG:1066's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY